Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -129.77 | N/A |
| PEG Ratio (TTM) | -1.56 | N/A |
| P/S Ratio (TTM) | 0.08 | N/A |
| P/B Ratio (TTM) | 0.85 | N/A |
| P/FCF Ratio (TTM) | -6.98 | N/A |
| Price to 5YR AVG Earnings Ratio | -52.93 | N/A |
| Price to 5YR AVG FCF Ratio | 3.81 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.10% | N/A |
| ROE (TTM) | -0.60% | N/A |
| Net Profit Margin (TTM) | -0.07% | N/A |
| ROIC 5YR AVG | -1.10% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 341.40% | 31.57% | 5.58% |
| Revenue | -0.26% | 5.58% | 2.64% |
| Net Income | 342.36% | 25.39% | -0.14% |
| Cash Flow | 19.97% | 15.16% | 8.72% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.41 | N/A |
| Quick Ratio (TTM) | 0.29 | N/A |
| D/E Ratio (TTM) | 4.19 | N/A |
| Interest Coverage (TTM) | 0.62 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.80 | N/A |
| LTL to 5YR AVG FCF | 16.35 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.73% | N/A |